Innovative Medicines Canada Announces New President

Innovative Medicines Canada, one of the CCTCC's funding organizations, welcomes Pamela Fralick as President of the association effective today.

Ms. Fralick comes to Innovative Medicines Canada as a proven healthcare leader, with a wealth of experience advancing critical healthcare initiatives and a deep understanding of public policy and organizational management.
 
For more information on this announcement, please click here